Current and Future Role of Interferon Beta in the Therapy of Multiple Sclerosis-Reference-Cited by-同舟云学术

Current and Future Role of Interferon Beta in the Therapy of Multiple Sclerosis

Published:2010-10 Issue:10 Volume:30 Page:715-726
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Farrell Rachel A.¹,Giovannoni Gavin²

Affiliation:

1. Institute of Neurology, University College London, London, United Kingdom.

2. Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2010.0089

Reference142 articles.

1. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ

2. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis

3. Extensive Cortical Remyelination in Patients with Chronic Multiple Sclerosis

4. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis

5. Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis;Cureus;2021-02-09

2. Efficacy of alemtuzumab and natalizumab in the treatment of different stages of multiple sclerosis patients;Medicine;2018-02

3. [Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy];Farmeconomia. Health economics and therapeutic pathways;2016-03-31

4. Immunogenicity considerations;Biosimilars and Interchangeable Biologics;2015-12-02

5. Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β;Journal of Interferon & Cytokine Research;2013-11